258 related articles for article (PubMed ID: 34794851)
1. Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline.
Little K; Llorián-Salvador M; Scullion S; Hernández C; Simó-Servat O; Del Marco A; Bosma E; Vargas-Soria M; Carranza-Naval MJ; Van Bergen T; Galbiati S; Viganò I; Musi CA; Schlingemann R; Feyen J; Borsello T; Zerbini G; Klaassen I; Garcia-Alloza M; Simó R; Stitt AW;
Trends Endocrinol Metab; 2022 Jan; 33(1):50-71. PubMed ID: 34794851
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective.
Simó R; Ciudin A; Simó-Servat O; Hernández C
Acta Diabetol; 2017 May; 54(5):417-424. PubMed ID: 28210868
[TBL] [Abstract][Full Text] [Related]
3. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina.
Oshitari T
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769249
[TBL] [Abstract][Full Text] [Related]
4. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
Pugazhenthi S; Qin L; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
[TBL] [Abstract][Full Text] [Related]
5.
Majimbi M; McLenachan S; Nesbit M; Chen FK; Lam V; Mamo J; Takechi R
Front Endocrinol (Lausanne); 2023; 14():1224418. PubMed ID: 37850093
[TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease.
Jash K; Gondaliya P; Kirave P; Kulkarni B; Sunkaria A; Kalia K
Drug Dev Res; 2020 Apr; 81(2):144-164. PubMed ID: 31820484
[TBL] [Abstract][Full Text] [Related]
7. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
[TBL] [Abstract][Full Text] [Related]
8. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy.
Xu J; Chen LJ; Yu J; Wang HJ; Zhang F; Liu Q; Wu J
Cell Physiol Biochem; 2018; 48(2):705-717. PubMed ID: 30025404
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products and diabetic retinopathy.
Chen M; Curtis TM; Stitt AW
Curr Med Chem; 2013; 20(26):3234-40. PubMed ID: 23745547
[TBL] [Abstract][Full Text] [Related]
11. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK
J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187
[TBL] [Abstract][Full Text] [Related]
12. Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products.
Curtis TM; Hamilton R; Yong PH; McVicar CM; Berner A; Pringle R; Uchida K; Nagai R; Brockbank S; Stitt AW
Diabetologia; 2011 Mar; 54(3):690-8. PubMed ID: 21116609
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline.
Ehtewish H; Arredouani A; El-Agnaf O
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682821
[TBL] [Abstract][Full Text] [Related]
14. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
Murata T; Nagai R; Ishibashi T; Inomuta H; Ikeda K; Horiuchi S
Diabetologia; 1997 Jul; 40(7):764-9. PubMed ID: 9243096
[TBL] [Abstract][Full Text] [Related]
15. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
16. AGEs and diabetic retinopathy.
Stitt AW
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4867-74. PubMed ID: 20876889
[TBL] [Abstract][Full Text] [Related]
17. The role of advanced glycation in the pathogenesis of diabetic retinopathy.
Stitt AW
Exp Mol Pathol; 2003 Aug; 75(1):95-108. PubMed ID: 12834631
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Takeuchi M; Yamagishi S
Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.
Stitt AW; Frizzell N; Thorpe SR
Curr Pharm Des; 2004; 10(27):3349-60. PubMed ID: 15544520
[TBL] [Abstract][Full Text] [Related]
20. AGEs, RAGE, and diabetic retinopathy.
Zong H; Ward M; Stitt AW
Curr Diab Rep; 2011 Aug; 11(4):244-52. PubMed ID: 21590515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
